Direkt zum Inhalt
Merck

An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury.

Neuron (2021-10-28)
Brett J Hilton, Andreas Husch, Barbara Schaffran, Tien-Chen Lin, Emily R Burnside, Sebastian Dupraz, Max Schelski, Jisoo Kim, Johannes Alexander Müller, Susanne Schoch, Cordelia Imig, Nils Brose, Frank Bradke
ZUSAMMENFASSUNG

Axons in the adult mammalian central nervous system fail to regenerate after spinal cord injury. Neurons lose their capacity to regenerate during development, but the intracellular processes underlying this loss are unclear. We found that critical components of the presynaptic active zone prevent axon regeneration in adult mice. Transcriptomic analysis combined with live-cell imaging revealed that adult primary sensory neurons downregulate molecular constituents of the synapse as they acquire the ability to rapidly grow their axons. Pharmacogenetic reduction of neuronal excitability stimulated axon regeneration after adult spinal cord injury. Genetic gain- and loss-of-function experiments uncovered that essential synaptic vesicle priming proteins of the presynaptic active zone, but not clostridial-toxin-sensitive VAMP-family SNARE proteins, inhibit axon regeneration. Systemic administration of Baclofen reduced voltage-dependent Ca2+ influx in primary sensory neurons and promoted their regeneration after spinal cord injury. These findings indicate that functional presynaptic active zones constitute a major barrier to axon regeneration.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Roche
cOmplete, Mini, EDTA-freier Protease-Inhibitor-Cocktail, Protease Inhibitor Cocktail Tablets provided in a glass vial, Tablets provided in a glass vial
Sigma-Aldrich
Albumin aus Rinderserum, heat shock fraction, protease free, pH 7, ≥98%
Sigma-Aldrich
Tetraethylammoniumchlorid, ≥98% (titration)
Sigma-Aldrich
4-Aminopyridin, 98%
Sigma-Aldrich
Anti-β-Tubulin-III in Kaninchen hergestellte Antikörper, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Collagenase aus Clostridium histolyticum, 0.2 μm filtered, suitable for release of physiologically active rat hepatocytes, Type IV-S, 0.5-5.0 FALGPA units/mg solid, ≥125 CDU/mg solid
Sigma-Aldrich
Aufgereinigter Anti-NeuN-Antikörper, from guinea pig, purified by affinity chromatography
Sigma-Aldrich
(±)-Baclofen, ≥98% (HPLC), solid
Sigma-Aldrich
Roscovitine, ≥98% (TLC)
Sigma-Aldrich
GV-58, ≥97% (HPLC)